These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 24246527)

  • 1. New insights provided by a comparison of impaired deformability with erythrocyte oxidative stress for sickle cell disease.
    Barodka VM; Nagababu E; Mohanty JG; Nyhan D; Berkowitz DE; Rifkind JM; Strouse JJ
    Blood Cells Mol Dis; 2014 Apr; 52(4):230-5. PubMed ID: 24246527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro exposure to hydroxyurea reduces sickle red blood cell deformability.
    Huang Z; Louderback JG; King SB; Ballas SK; Kim-Shapiro DB
    Am J Hematol; 2001 Jul; 67(3):151-6. PubMed ID: 11391710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Erythrocyte and plasma oxidative stress appears to be compensated in patients with sickle cell disease during a period of relative health, despite the presence of known oxidative agents.
    Detterich JA; Liu H; Suriany S; Kato RM; Chalacheva P; Tedla B; Shah PM; Khoo MC; Wood JC; Coates TD; Milne GL; Oh JY; Patel RP; Forman HJ
    Free Radic Biol Med; 2019 Sep; 141():408-415. PubMed ID: 31279092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kinetics of increased deformability of deoxygenated sickle cells upon oxygenation.
    Huang Z; Hearne L; Irby CE; King SB; Ballas SK; Kim-Shapiro DB
    Biophys J; 2003 Oct; 85(4):2374-83. PubMed ID: 14507701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The clinical pathophysiology of sickle cell disease.
    Embury SH
    Annu Rev Med; 1986; 37():361-76. PubMed ID: 2423018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of sickle hemoglobin polymerization and membrane properties on deformability of sickle erythrocytes in the microcirculation.
    Dong C; Chadwick RS; Schechter AN
    Biophys J; 1992 Sep; 63(3):774-83. PubMed ID: 1420913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of Band 3 tyrosine phosphorylation: a new mechanism for treatment of sickle cell disease.
    Noomuna P; Risinger M; Zhou S; Seu K; Man Y; An R; Sheik DA; Wan J; Little JA; Gurkan UA; Turrini FM; Kalfa T; Low PS
    Br J Haematol; 2020 Aug; 190(4):599-609. PubMed ID: 32346864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemolysis in sickle cell disease.
    Bensinger TA; Gillette PN
    Arch Intern Med; 1974 Apr; 133(4):624-31. PubMed ID: 4594397
    [No Abstract]   [Full Text] [Related]  

  • 9. Sickle cell rheology is determined by polymer fraction--not cell morphology.
    Hiruma H; Noguchi CT; Uyesaka N; Hasegawa S; Blanchette-Mackie EJ; Schechter AN; Rodgers GP
    Am J Hematol; 1995 Jan; 48(1):19-28. PubMed ID: 7832188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gel-filtration of sickle erythrocytes: separation based on cell deformability.
    Baerlocher GM; Meiselman HJ; Reinhart WH
    Clin Hemorheol Microcirc; 2001; 24(1):11-8. PubMed ID: 11345229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of pH on the rheologic and antisickling effects of dimethyl adipimidate.
    Pennathur-Das R; Lande WM; Mentzer WC; Mohandas N; Preisler H; Kleman KM; Heath RH; Lubin BH
    J Lab Clin Med; 1984 Nov; 104(5):718-29. PubMed ID: 6491469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemoglobin aggregation and pseudosickling in vitro of hemoglobin Setif-containing erythrocytes.
    Noguchi CT; Mohandas N; Blanchette-Mackie J; Mackie S; Raik E; Charache S
    Am J Hematol; 1991 Feb; 36(2):131-9. PubMed ID: 2012063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intracellular polymerization of sickle hemoglobin: disease severity and therapeutic goals.
    Noguchi CT; Rodgers GP; Schechter AN
    Prog Clin Biol Res; 1987; 240():381-91. PubMed ID: 3615501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Electrical Impedance Characterization of Erythrocyte Response to Cyclic Hypoxia in Sickle Cell Disease.
    Liu J; Qiang Y; Alvarez O; Du E
    ACS Sens; 2019 Jul; 4(7):1783-1790. PubMed ID: 31083931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of polymerization tendency on haematological, rheological and clinical parameters in sickle cell anaemia.
    Keidan AJ; Sowter MC; Johnson CS; Noguchi CT; Girling AJ; Stevens SM; Stuart J
    Br J Haematol; 1989 Apr; 71(4):551-7. PubMed ID: 2469459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does higher red blood cell (RBC) lactate transporter activity explain impaired RBC deformability in sickle cell trait?
    Connes P; Sara F; Hardy-Dessources MD; Etienne-Julan M; Hue O
    Jpn J Physiol; 2005 Dec; 55(6):385-7. PubMed ID: 16441976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Red cell membrane injury in sickle cell anaemia.
    Palek J
    Br J Haematol; 1977 Jan; 35(1):1-9. PubMed ID: 322695
    [No Abstract]   [Full Text] [Related]  

  • 18. Established and experimental treatments for sickle cell disease.
    De Franceschi L; Corrocher R
    Haematologica; 2004 Mar; 89(3):348-56. PubMed ID: 15020275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A study of erythrocyte deformability in sickle cell disease.
    Reid HL; Obi GO
    Trop Geogr Med; 1982 Mar; 34(1):43-6. PubMed ID: 7080186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-uniformity of intracellular polymer formation in sickle erythrocytes: possible correlation with severity of hemolytic anemia.
    Noguchi CT; Schechter AN
    Am J Pediatr Hematol Oncol; 1984; 6(1):46-50. PubMed ID: 6711762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.